Atorvastatin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.
Category
HMG-COA Reductase Inhibitor
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH